AHEALTH | APEX HEALTHCARE BERHAD

2.61 (0.0%)
3 T-O (am): 0.000 (08:59:00)
Price updated as of: 16:59
Fundamental
Technical
Total Score
AHEALTH | APEX HEALTHCARE BERHAD

AHEALTH Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Chart:

AHEALTH Quarter Reports

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS		 Adj.
[M]		 NP [M]
(adj)		 NPM
(adj)		 EPS
(adj)		 E. QoQ
(adj)		 E. YoY
(adj)		 TTM EPS
(adj)
24 Nov 25 Q3 Sep 2025 3 31 Dec 2025 253.02 21.69 15.60 6.2% 0.00 2.18 5.1% 6.6% 17.1% 14.4%
20 Aug 25 Q2 Jun 2025 2 31 Dec 2025 240.75 24.59 18.82 7.8% 6.00 2.63 0.8% 0.8% 7.0% 20.4%
21 May 25 Q1 Mar 2025 1 31 Dec 2025 238.87 22.70 17.58 7.4% 0.00 2.46 0.6% 3.8% 30.6% 17.1%
26 Feb 25 Q4 Dec 2024 4 31 Dec 2024 237.50 22.10 13.46 5.7% 3.00 1.88 0.1% 1.0% 26.2% 32.9%
27 Nov 24 Q3 Sep 2024 3 31 Dec 2024 237.37 23.72 18.23 7.7% 3.00 2.55 0.6% 0.9% 22.9% 24.6%
21 Aug 24 Q2 Jun 2024 2 31 Dec 2024 238.74 29.08 23.64 9.9% 3.00 3.31 3.8% 11.0% 11.5% 92.8%
15 May 24 Q1 Mar 2024 1 31 Dec 2024 248.18 26.30 21.21 8.6% 0.00 2.97 3.4% 1.0% 5.7% 12.7%
21 Feb 24 Q4 Dec 2023 4 31 Dec 2023 240.00 28.64 20.06 8.4% 22.50 2.81 2.0% 8.8% 17.0% 42.4%
29 Nov 23 Q3 Sep 2023 3 31 Dec 2023 235.34 30.48 24.16 10.3% 0.00 3.38 9.4% 1.4% 92.7% 10.1%
23 Aug 23 Q2 Jun 2023 2 31 Dec 2023 215.03 334.52 329.48 153.2% 2.50 46.13 12.5% 2.8% 1256.9% 1302.7%
24 May 23 Q1 Mar 2023 1 31 Dec 2023 245.80 29.67 24.28 9.9% 0.00 5.12 11.5% 13.8% 30.3% 54.0%
22 Feb 23 Q4 Dec 2022 4 31 Dec 2022 220.49 40.29 34.84 15.8% 5.50 7.34 5.0% 11.6% 29.6% 68.2%
16 Nov 22 Q3 Sep 2022 3 31 Dec 2022 232.08 32.40 26.88 11.6% 0.00 5.67 10.9% 10.0% 14.4% 91.9%
16 Aug 22 Q2 Jun 2022 2 31 Dec 2022 209.25 27.85 23.49 11.2% 3.00 4.95 3.1% 14.6% 49.0% 83.2%
18 May 22 Q1 Mar 2022 1 31 Dec 2022 215.92 19.82 15.77 7.3% 0.00 3.33 9.2% 20.3% 23.8% 32.8%
23 Feb 22 Q4 Dec 2021 4 31 Dec 2021 197.66 25.30 20.70 10.5% 9.00 4.37 6.3% 22.3% 47.8% 43.8%
17 Nov 21 Q3 Sep 2021 3 31 Dec 2021 211.06 18.55 14.01 6.6% 0.00 2.96 15.6% 24.8% 9.2% 1.5%
19 Aug 21 Q2 Jun 2021 2 31 Dec 2021 182.56 16.12 12.82 7.0% 2.50 2.71 1.7% 4.5% 8.0% 1.6%
20 May 21 Q1 Mar 2021 1 31 Dec 2021 179.49 15.44 11.88 6.6% 0.00 2.51 11.1% 7.2% 17.5% 17.3%
25 Feb 21 Q4 Dec 2020 4 31 Dec 2020 161.58 18.40 14.39 8.9% 2.80 3.04 4.5% 5.3% 1.2% 2.8%
19 Nov 20 Q3 Sep 2020 3 31 Dec 2020 169.12 17.49 14.22 8.4% 0.00 3.01 3.2% 6.4% 9.1% 0.7%
26 Aug 20 Q2 Jun 2020 2 31 Dec 2020 174.73 16.34 13.03 7.5% 1.70 2.76 9.6% 9.7% 9.3% 1.4%
21 May 20 Q1 Mar 2020 1 31 Dec 2020 193.31 17.94 14.37 7.4% 0.00 3.05 13.3% 8.5% 2.6% 26.1%
19 Feb 20 Q4 Dec 2019 4 31 Dec 2019 170.63 18.48 14.00 8.2% 2.00 2.97 5.5% 4.6% 0.8% 16.7%
21 Nov 19 Q3 Sep 2019 3 31 Dec 2019 180.65 17.12 14.12 7.8% 0.00 3.00 13.4% 15.8% 6.8% 3.1%
21 Aug 19 Q2 Jun 2019 2 31 Dec 2019 159.27 16.18 13.22 8.3% 1.70 2.81 10.6% 5.4% 16.0% 0.3%
23 May 19 Q1 Mar 2019 1 31 Dec 2019 178.23 14.54 11.40 6.4% 0.00 9.71 9.3% 16.8% 32.2% 10.9%
28 Feb 19 Q4 Dec 2018 4 31 Dec 2018 163.06 16.74 16.80 10.3% 7.00 14.33 4.6% 3.4% 22.7% 49.1%
16 Aug 18 Q2 Jun 2018 2 31 Dec 2018 155.95 17.37 13.70 8.8% 6.50 11.69 7.4% 0.4% 3.9% 33.0%
24 May 18 Q1 Mar 2018 1 31 Dec 2018 168.40 16.53 13.18 7.8% 0.00 11.25 10.4% 8.9% 3.0% 30.6%
22 Feb 18 Q4 Dec 2017 4 31 Dec 2017 152.59 16.38 12.80 8.4% 6.50 10.93 3.3% 5.8% 13.6% 89.5%
14 Nov 17 Q3 Sep 2017 3 31 Dec 2017 157.73 13.30 11.27 7.2% 0.00 9.62 1.6% 10.3% 9.4% 29.0%
16 Aug 17 Q2 Jun 2017 2 31 Dec 2017 155.30 13.45 10.30 6.6% 5.50 8.79 0.4% 5.9% 2.0% 6.7%
17 May 17 Q1 Mar 2017 1 31 Dec 2017 154.65 12.91 10.09 6.5% 0.00 8.61 7.3% 4.9% 49.4% 2.8%
23 Feb 17 Q4 Dec 2016 4 31 Dec 2016 144.15 10.08 6.76 4.7% 6.00 5.77 0.8% 7.4% 22.7% 51.1%
15 Nov 16 Q3 Sep 2016 3 31 Dec 2016 142.96 11.54 8.74 6.1% 0.00 7.46 2.5% 11.4% 9.5% 62.4%
17 Aug 16 Q2 Jun 2016 2 31 Dec 2016 146.69 12.31 9.65 6.6% 5.50 8.24 0.5% 18.0% 1.7% 46.1%
18 May 16 Q1 Mar 2016 1 31 Dec 2016 147.48 12.37 9.81 6.7% 0.00 8.38 9.8% 5.3% 28.9% 16.2%
25 Feb 16 Q4 Dec 2015 4 31 Dec 2015 134.25 16.91 13.81 10.3% 6.00 11.79 4.7% 8.9% 156.6% 44.6%
26 Nov 15 Q3 Sep 2015 3 31 Dec 2015 128.27 7.72 5.38 4.2% 0.00 4.59 3.2% 4.7% 18.5% 27.4%
19 Aug 15 Q2 Jun 2015 2 31 Dec 2015 124.28 9.08 6.60 5.3% 5.00 5.64 11.3% 1.5% 21.8% 12.6%
20 May 15 Q1 Mar 2015 1 31 Dec 2015 140.06 11.88 8.45 6.0% 0.00 7.21 13.6% 7.0% 11.5% 10.8%
25 Feb 15 31/12/14 4 31/12/14 123.31 12.67 9.54 7.7% 6.00 8.13 0.7% 16.1% 28.8% 25.3%

AHEALTH Historical Dividends

AHEALTH Financial Ratios

EPS 9.08 sen
Trailing PE (Sector Median: 17.4) 28.8
PEG 28.8
Altman Z 2.5
Beaver 0.263
Current Ratio 3.35
Debt-Equity (DE) Ratio 0.28
FCF Yield 2.17 %
Revenue QoQ 5.1 %
Revenue YoY 6.59%
Profit QoQ -17.1 %
Profit YoY -14.43 %
Profit Margin (Sector Median: 5.7) 6.75 %
ROE (ROIC: 8.04) 8.4 %
Dividend Per Share (DPS) 9.0 sen
Dividend Yield (DY) 3.45 %

AHEALTH Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 17.4)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 5.7)
ROE (ROIC: 8.39)
Altman Z

AHEALTH Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Average Analysts FV based on 1 rating(s)
Graham Formula
Graham Number
Net Tangible Asset (NTA) 1.09
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 16.0
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 243.8
Expected Revenue (M) 2021.55
Expected Growth (%) 17.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

AHEALTH Directors Share Purchases (Beta)


MR KEE KIRK CHUEN added 29500.0 units announced on 22 Jan 2024 at ~RM2.54

DR KEE KIRK CHIN added 29500.0 units announced on 22 Jan 2024 at ~RM2.54

MR KEE KIRK CHUEN added 115000.0 units announced on 12 Jan 2024 at ~RM2.57

DR KEE KIRK CHIN added 115000.0 units announced on 12 Jan 2024 at ~RM2.57

DR KEE KIRK CHIN added 27900.0 units announced on 27 Oct 2023 at ~RM2.4

MR KEE KIRK CHUEN added 27900.0 units announced on 27 Oct 2023 at ~RM2.4

DR KEE KIRK CHIN added 108000.0 units announced on 25 Oct 2023 at ~RM2.4

MR KEE KIRK CHUEN added 108000.0 units announced on 25 Oct 2023 at ~RM2.4

MR KEE KIRK CHUEN added 16200.0 units announced on 09 Oct 2023 at ~RM2.43

DR KEE KIRK CHIN added 16200.0 units announced on 09 Oct 2023 at ~RM2.43

MR KEE KIRK CHUEN added 35000.0 units announced on 05 Oct 2023 at ~RM2.44

DR KEE KIRK CHIN added 35000.0 units announced on 05 Oct 2023 at ~RM2.44

DR KEE KIRK CHIN added 195000.0 units announced on 26 Sep 2023 at ~RM2.46

MR KEE KIRK CHUEN added 195000.0 units announced on 26 Sep 2023 at ~RM2.46

MR KEE KIRK CHUEN added 46000.0 units announced on 22 Sep 2023 at ~RM2.49

DR KEE KIRK CHIN added 46000.0 units announced on 22 Sep 2023 at ~RM2.49

MR KEE KIRK CHUEN added 75000.0 units announced on 20 Sep 2023 at ~RM2.48

DR KEE KIRK CHIN added 75000.0 units announced on 20 Sep 2023 at ~RM2.48

MR KEE KIRK CHUEN added 114000.0 units announced on 13 Jul 2023 at ~RM2.39

DR KEE KIRK CHIN added 114000.0 units announced on 13 Jul 2023 at ~RM2.39

MR KEE KIRK CHUEN added 74000.0 units announced on 01 Jun 2023 at ~RM3.87

DR KEE KIRK CHIN added 74000.0 units announced on 01 Jun 2023 at ~RM3.87

MR LEONG KHAI CHEONG added 81600.0 units announced on 17 Oct 2022 at ~RM3.11

DR KEE KIRK CHIN added 10000.0 units announced on 17 Oct 2022 at ~RM3.11

MR KEE KIRK CHUEN added 10000.0 units announced on 17 Oct 2022 at ~RM3.11

MR KEE KIRK CHUEN added 172200.0 units announced on 14 Oct 2022 at ~RM3.06

DR KEE KIRK CHIN added 172200.0 units announced on 14 Oct 2022 at ~RM3.06

DR KEE KIRK CHIN added 23400.0 units announced on 29 Sep 2022 at ~RM3.16

MR KEE KIRK CHUEN added 23400.0 units announced on 29 Sep 2022 at ~RM3.16

MR KEE KIRK CHUEN added 29000.0 units announced on 19 Sep 2022 at ~RM3.19

DR KEE KIRK CHIN added 29000.0 units announced on 19 Sep 2022 at ~RM3.19

MR KEE KIRK CHUEN added 30000.0 units announced on 14 Jul 2022 at ~RM2.92

MR ROBERT DOBSON MILLNER added 44000.0 units announced on 12 Jul 2022 at ~RM2.92

DR KEE KIRK CHIN added 152000.0 units announced on 12 Jul 2022 at ~RM2.92

MR KEE KIRK CHUEN added 152000.0 units announced on 12 Jul 2022 at ~RM2.92

MR ROBERT DOBSON MILLNER added 76000.0 units announced on 08 Jul 2022 at ~RM2.9

MR ROBERT DOBSON MILLNER added 80000.0 units announced on 07 Jul 2022 at ~RM2.85

MR KEE KIRK CHUEN added 10000.0 units announced on 04 Jan 2022 at ~RM2.55

DR KEE KIRK CHIN added 10000.0 units announced on 04 Jan 2022 at ~RM2.55

MR KEE KIRK CHUEN added 30000.0 units announced on 13 Dec 2021 at ~RM2.57

DR KEE KIRK CHIN added 1000000.0 units announced on 11 Jun 2021 at ~RM2.9

MR KEE KIRK CHUEN added 1000000.0 units announced on 11 Jun 2021 at ~RM2.9

MR KEE KIRK CHUEN added 74000.0 units announced on 25 May 2021 at ~RM2.89

DR KEE KIRK CHIN added 74000.0 units announced on 25 May 2021 at ~RM2.89

DR KEE KIRK CHIN added 58000.0 units announced on 24 May 2021 at ~RM2.83

MR KEE KIRK CHUEN added 58000.0 units announced on 24 May 2021 at ~RM2.83

MR KEE KIRK CHUEN added 50000.0 units announced on 12 Mar 2021 at ~RM2.87

MR KEE KIRK CHUEN added 104000.0 units announced on 26 Jan 2021 at ~RM3.35

DR KEE KIRK CHIN added 104000.0 units announced on 26 Jan 2021 at ~RM3.35

AHEALTH Summary


Market Cap: 1885 M.

Market Cap Class: Large caps

Number of Shares: 722 M.

Adjusted Float: 30.7%.

Stock highly correlated with

UZMA (93%)

TRC (92%)

PARAGON (90%)

MRCB (88%)

Apex Healthcare Berhad, incorporated in 1962 and headquartered in Melaka, Malaysia, is a leading pharmaceutical company specializing in manufacturing, distribution, and retail of pharmaceuticals, consumer healthcare products, and medical devices. The company operates a fully integrated supply chain, manufacturing a broad range of off-patent generic pharmaceuticals, proprietary consumer healthcare products, and contract-manufactured medical devices, catering to both domestic and international markets. Through its extensive distribution network, Apex Healthcare supplies hospitals, clinics, pharmacies, and healthcare institutions, ensuring seamless market access for its products and business partners. The company is also involved in contract manufacturing for orthopaedic devices, strengthening its presence in the global medical technology sector. With a strong focus on R&D, regulatory compliance, and digital transformation, Apex Healthcare Berhad continues to drive innovation, operational excellence, and sustainable growth in the evolving healthcare landscape​.

Sectors: Pharmaceuticals, Healthcare, Vaccine

Code: 7090

Website: http://www.apexhealthcare.com.my/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

AHEALTH Top Shareholdings

Updated on 07-Jan-2026

Shareholder % Value (M)
Pharmora Investment Holdings Pte Ltd ("Pharmora") 95.43% 1799.44
Pharmora Investment Holdings Pte Ltd 92.49% 1744.06
Apex Pharmacy Holdings Sdn Bhd 39.72% 748.99
Washington H. Soul Pattinson And Company Limited 29.61% 558.35
Lim Teh Realty Sdn Berhad 1.36% 25.65
Xepa Holdings Sdn Bhd 1.04% 19.61
Md Ali Bin Md Dewal 1.01% 19.05
Public Islamic Opportunities Fund 1.01% 19.05
iCapital.Biz Berhad 0.89% 16.78
Liew Yoon Yee 0.84% 15.84
Tan Su-Ann 0.84% 15.84
DBS Bank 0.79% 14.9
Public Strategic Smallcap Fund 0.79% 14.9
Apex Holdings Ltd 0.56% 10.56
Chan Heng Koon 0.53% 9.99
Teoh Choon Neo @ Ivy Teoh Choon Neo 0.48% 9.05
Public Focus Select Fund 0.47% 8.86
Singam A/L Kumarasamy 0.46% 8.67
Yeo Lee Hee 0.39% 7.35
Kee Kirk Chin 0.38% 7.17
Wong Yee Hui 0.34% 6.41
Oh Siew Heong 0.33% 6.22
Tan Jin Thai 0.32% 6.03
PB Islamic SmallCap Fund 0.31% 5.85
Leong Wai Kuen 0.28% 5.28
Susy Ding 0.28% 5.28
Phua Kiap Wite 0.25% 4.71
Leong Khai Cheong 0.23% 4.34
Lim Khuan Eng 0.22% 4.15
Lai Yoon Kee 0.22% 4.15
Medical Fund 0.21% 3.96
Frequently Asked Questions
Apex Healthcare Berhad, incorporated in 1962 and headquartered in Melaka, Malaysia, is a leading pharmaceutical company specializing in manufacturing, distribution, and retail of pharmaceuticals, consumer healthcare products, and medical devices. The company operates a fully integrated supply chain, manufacturing a broad range of off-patent generic pharmaceuticals, proprietary consumer healthcare products, and contract-manufactured medical devices, catering to both domestic and international markets. Through its extensive distribution network, Apex Healthcare supplies hospitals, clinics, pharmacies, and healthcare institutions, ensuring seamless market access for its products and business partners. The company is also involved in contract manufacturing for orthopaedic devices, strengthening its presence in the global medical technology sector. With a strong focus on R&D, regulatory compliance, and digital transformation, Apex Healthcare Berhad continues to drive innovation, operational excellence, and sustainable growth in the evolving healthcare landscape​. The company is listed on Bursa Malaysia and operates in the Pharmaceuticals, Healthcare and Vaccine sectors.
Yes, APEX HEALTHCARE BERHAD is listed as Shariah-compliant.
The latest share price of APEX HEALTHCARE BERHAD is RM 2.61 updated on 27 January 2026 16:59.
As of now, APEX HEALTHCARE BERHAD has a market capitalization of 1885M based on the latest financial data.
iSaham's technical analysis indicates that APEX HEALTHCARE BERHAD's support level is at RM 2.57 and its resistance level is at RM 2.63, based on moving averages and price patterns.
The 52-week high for APEX HEALTHCARE BERHAD is RM 2.65
APEX HEALTHCARE BERHAD's share price has increased by 8.75% year-to-date, influenced by market trends and company performance.
APEX HEALTHCARE BERHAD declared a dividend of 9.0 sen for the year 2025-11-24. View more details on APEX HEALTHCARE BERHAD's Historical Dividends page.
The main shareholders of APEX HEALTHCARE BERHAD include Pharmora Investment Holdings Pte Ltd ("Pharmora"), Pharmora Investment Holdings Pte Ltd and Apex Pharmacy Holdings Sdn Bhd. View more on APEX HEALTHCARE BERHAD Top Shareholders page.
You can buy APEX HEALTHCARE BERHAD shares through any licensed online broker or trading platform registered with Bursa Malaysia. If you're new to investing, iSaham can help you open an account with M+ Online, one of Malaysia's leading brokers.
When you open your M+ account through the iSaham team, you can get iSaham Pro for free as a bonus offer.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.